| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.9759 | 
      | Human Intestinal Absorption | HIA+ | 0.9804 | 
      | Caco-2 Permeability | Caco2- | 0.5417 | 
      | P-glycoprotein Substrate | Non-substrate | 0.7055 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.5752 | 
                                                     | Non-inhibitor | 0.9906 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8505 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.4732 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.7792 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.7382 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.5000 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.5541 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.6112 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.8912 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.5527 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.5418 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8089 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8733 | 
                                                                    | Non-inhibitor | 0.7680 | 
      | AMES Toxicity | Non AMES toxic | 0.6895 | 
      | Carcinogens | Non-carcinogens | 0.7193 | 
      | Fish Toxicity | Low FHMT | 0.5596 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.7471 | 
      | Honey Bee Toxicity | High HBT | 0.7855 | 
      | Biodegradation | Not ready biodegradable | 0.9835 | 
      | Acute Oral Toxicity | II | 0.7258 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6036 |